The Melbourne-based venture capital firm, Brandon Capital Partners, focuses on investing in innovative life science ventures, such as pharmaceuticals, biotechnology, healthcare devices, and digital health. With a mission to generate quality returns for Australia's leading superannuation funds, the company collaborates closely with entrepreneurs to build businesses and create value for all stakeholders involved. Since its establishment in 2007, Brandon Capital Partners has been actively investing in the life sciences, oncology, and manufacturing sectors in Australia and New Zealand.